A. Robidoux

7.5k total citations · 3 hit papers
29 papers, 4.7k citations indexed

About

A. Robidoux is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Robidoux has authored 29 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Robidoux's work include Breast Cancer Treatment Studies (12 papers), BRCA gene mutations in cancer (7 papers) and Cancer Treatment and Pharmacology (7 papers). A. Robidoux is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), BRCA gene mutations in cancer (7 papers) and Cancer Treatment and Pharmacology (7 papers). A. Robidoux collaborates with scholars based in United States, Canada and Belgium. A. Robidoux's co-authors include Norman Wolmark, Edwin R. Fisher, Anatolio B. Cruz, D. Lawrence Wickerham, Bernard Fisher, Richard G. Margolese, A Brown, James L. Hoehn, Arthur P. DeCillis and E.P. Mamounas and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

A. Robidoux

29 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

1998 1.7k citations Bernard Fisher, John Bryant et al. Journal of Clinical Oncology profile →
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

1997 1.4k citations Bernard Fisher, A Brown et al. Journal of Clinical Oncology profile →
Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011

1988 754 citations B. Fisher, Norman Wolmark et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Robidoux United States	15	2.8k	2.8k	1.7k	1.4k	703	29	4.7k
James L. Hoehn United States	12	2.8k 1.0×	3.9k 1.4×	2.2k 1.3×	1.3k 1.0×	785 1.1×	19	5.4k
Arthur P. DeCillis United States	14	2.5k 0.9×	3.1k 1.1×	1.7k 1.0×	780 0.6×	518 0.7×	25	5.4k
A Brown United States	14	2.3k 0.8×	3.1k 1.1×	1.6k 0.9×	761 0.6×	741 1.1×	19	4.2k
E.P. Mamounas United States	11	2.0k 0.7×	3.1k 1.1×	1.8k 1.1×	848 0.6×	501 0.7×	18	3.7k
Florentia Peintinger Austria	26	1.9k 0.7×	2.5k 0.9×	1.2k 0.7×	818 0.6×	658 0.9×	59	3.7k
Mirsada Begovič United States	12	1.9k 0.7×	2.1k 0.8×	1.1k 0.7×	755 0.5×	386 0.5×	19	3.2k
Georges Vlastos Switzerland	37	2.3k 0.8×	2.3k 0.9×	1.2k 0.7×	937 0.7×	372 0.5×	89	4.3k
Lawrence Wickerham United States	13	2.0k 0.7×	3.2k 1.2×	2.0k 1.2×	1.5k 1.1×	452 0.6×	19	4.6k
Julia S. Wong United States	29	1.6k 0.6×	2.6k 1.0×	1.5k 0.9×	774 0.6×	432 0.6×	83	3.7k
Luigi Cataliotti Italy	30	1.5k 0.5×	1.9k 0.7×	1.2k 0.7×	747 0.5×	342 0.5×	101	3.0k

Countries citing papers authored by A. Robidoux

Since Specialization

Citations

This map shows the geographic impact of A. Robidoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Robidoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Robidoux more than expected).

Fields of papers citing papers by A. Robidoux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Robidoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Robidoux. The network helps show where A. Robidoux may publish in the future.

Co-authorship network of co-authors of A. Robidoux

This figure shows the co-authorship network connecting the top 25 collaborators of A. Robidoux. A scholar is included among the top collaborators of A. Robidoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Robidoux. A. Robidoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robidoux, A., et al.. (2017). Use of the 21-gene Oncotype DX® Breast Recurrence Score™ (RS) assay in the neoadjuvant treatment setting. The Breast. 32. S80–S80. 1 indexed citations

Robidoux, A., Jame Abraham, Nicla La Verde, et al.. (2016). Abstract PD5-04: NSABP FB-7: A phase II randomized trial evaluating neoadjuvant therapy with weekly paclitaxel (P) plus neratinib (N) or trastuzumab (T) or neratinib and trastuzumab (N+T) followed by doxorubicin and cyclophosphamide (AC) with postoperative T in women with locally advanced HER2-positive breast cancer. Cancer Research. 76(4_Supplement). PD5–4. 12 indexed citations

Tan, Antoinette R., Priya Rastogi, Samuel A. Jacobs, et al.. (2014). Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study. Breast Cancer Research and Treatment. 149(1). 163–169. 14 indexed citations

Ghadirian, P, A. Robidoux, Edgard Nassif, et al.. (2013). Screening for BRCA1 and BRCA2 mutations among French‐Canadian breast cancer cases attending an outpatient clinic in Montreal. Clinical Genetics. 85(1). 31–35. 12 indexed citations

Aebi, Stefan, Shari Gelber, István Láng, et al.. (2012). Abstract S3-2: Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02). Cancer Research. 72(24_Supplement). S3–2. 10 indexed citations

Lembersky, BC, Louis Fehrenbacher, CI Falkson, et al.. (2011). S2-3: NSABP Protocol B-34: A Clinical Trial Comparing Adjuvant Clodronate vs. Placebo in Early Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Tamoxifen or No Therapy – Final Analysis.. Cancer Research. 71(24_Supplement). S2–3. 14 indexed citations

Grunfeld, Eva, Jim A. Julian, Gregory R. Pond, et al.. (2011). Results of a multicenter randomized trial to evaluate a survivorship care plan for breast cancer survivors.. Journal of Clinical Oncology. 29(15_suppl). 9005–9005. 5 indexed citations

Bear, Harry D., Gong Tang, Priya Rastogi, et al.. (2011). The effect on pCR of bevacizumab and/or antimetabolites added to standard neoadjuvant chemotherapy: NSABP protocol B-40.. Journal of Clinical Oncology. 29(18_suppl). LBA1005–LBA1005. 33 indexed citations

Cantin, Guy, Jawaid Younus, Lawrence Panasci, et al.. (2010). An open-label, phase II study of weekly nab-paclitaxel as first-line therapy for patients (pts) with metastatic breast cancer (MBC): Safety update.. Journal of Clinical Oncology. 28(15_suppl). 1127–1127. 5 indexed citations

10.

Ghadirian, P, A. Robidoux, Robert E. Royer, et al.. (2009). The Contribution of Founder Mutations to Early-Onset Breast Cancer in French-Canadian Women.. Cancer Research. 69(24_Supplement). 902–902. 3 indexed citations

11.

Ghadirian, P, A. Robidoux, Ping Zhang, et al.. (2009). The contribution of founder mutations to early‐onset breast cancer in French‐Canadian women. Clinical Genetics. 76(5). 421–426. 27 indexed citations

12.

Lauzier, Sophie, Elizabeth Maunsell, Mélanie Drolet, et al.. (2008). Wage Losses in the Year After Breast Cancer: Extent and Determinants Among Canadian Women. JNCI Journal of the National Cancer Institute. 100(5). 321–332. 117 indexed citations

13.

Nkondjock, André, et al.. (2006). Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Research and Treatment. 98(3). 285–294. 84 indexed citations

14.

Chappuis, Pierre O., Nancy Hamel, Jean Deschênes, et al.. (2001). Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer. Clinical Genetics. 59(6). 418–423. 14 indexed citations

15.

Taillefer, Raymond, et al.. (1998). Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.. PubMed. 39(3). 459–64. 46 indexed citations

16.

Fisher, Bernard, John Bryant, Norman Wolmark, et al.. (1998). Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.. Journal of Clinical Oncology. 16(8). 2672–2685. 1688 indexed citations breakdown →

17.

Fisher, Bernard, A Brown, E.P. Mamounas, et al.. (1997). Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.. Journal of Clinical Oncology. 15(7). 2483–2493. 1373 indexed citations breakdown →

18.

Peters, George N., Carl G. Kardinal, A. Robidoux, & Gabriel N. Hortobágyi. (1995). Inflammatory breast cancer: what is the appropriate therapy for patients who have a clinical response to induction chemotherapy?. PubMed. 22(5). xiv, xxi, xxvi, xxxii–xiv, xxi, xxvi, xxxii. 2 indexed citations

19.

Wolmark, Norman, Howard E. Rockette, D. Lawrence Wickerham, et al.. (1990). Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02.. Journal of Clinical Oncology. 8(9). 1466–1475. 173 indexed citations

20.

Fisher, B., Norman Wolmark, Howard E. Rockette, et al.. (1988). Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011. JNCI Journal of the National Cancer Institute. 80(1). 21–29. 754 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact